Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 8, 2026 · Item 5.07
SUTRO BIOPHARMA, INC.
6
Item 5.07
Jun 8, 2026
| Form type | Current report (Form 8-K) |
| Event summary | Item 5.07 |
| Primary topic | Item 5.07 |
| About this form | Public companies file this within four business days when something important happens that investors should know about, before the next quarterly report. |
| Why this was filed | SUTRO BIOPHARMA, INC. filed this 8-K to disclose: ) 111 Oyster Point Blvd , South San Francisco , California , 94080 (Address of principal executive offices) (Zip Code) ( 650 ) 881-6500 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy t… |
| Labor angle | Watch for Item 2.05 (restructuring or severance), Item 5.02 (leadership changes), and Item 1.01 (major contracts that can precede workforce shifts). |
| Period of report | Jun 5, 2026 |
| Accession number | 0001193125-26-261658 |
| Reported items | Item 5.07 See Analysis tab for workforce implications |
